# Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 163538 XX

> **NCT01587391** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Placebo to BI 163538 XX
- **DRUG:** BI 163538 XX

## Key facts

- **NCT ID:** NCT01587391
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2013-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01587391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01587391, "Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 163538 XX". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01587391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*